ReviewBMJ open diabetes research & care2022

Controlling glycemic variability in people living with type 1 diabetes receiving insulin glargine 300 U/mL (Gla-300).

Julia K Mader et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.